These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20804707)

  • 1. Determining the C-reactive protein level in patients with different clinical forms of chagas disease.
    Aparecida da Silva C; Fattori A; Sousa AL; Mazon SB; Monte Alegre S; Almeida EA; Guariento ME
    Rev Esp Cardiol; 2010 Sep; 63(9):1096-9. PubMed ID: 20804707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure].
    López L; Arai K; Giménez E; Jiménez M; Pascuzo C; Rodríguez-Bonfante C; Bonfante-Cabarcas R
    Rev Esp Cardiol; 2006 Jan; 59(1):50-6. PubMed ID: 16434004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADENOSINE DEAMINASE ACTIVITY AND SERUM C-REACTIVE PROTEIN AS PROGNOSTIC MARKERS OF CHAGAS DISEASE SEVERITY.
    Bravo-Tobar ID; Nello-Pérez C; Fernández A; Mogollón N; Pérez MC; Verde J; Concepción JL; Rodriguez-Bonfante C; Bonfante-Cabarcas R
    Rev Inst Med Trop Sao Paulo; 2015; 57(5):385-92. PubMed ID: 26603224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
    Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease.
    Vasconcelos RH; Amaral FN; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2010 Oct; 71(10):964-7. PubMed ID: 20659514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico.
    Sánchez-Guillén Mdel C; López-Colombo A; Ordóñez-Toquero G; Gomez-Albino I; Ramos-Jimenez J; Torres-Rasgado E; Salgado-Rosas H; Romero-Díaz M; Pulido-Pérez P; Pérez-Fuentes R
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):733-40. PubMed ID: 17160280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
    Gallerano RR; Sosa RR
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia.
    Medrano-Mercado N; Luz MR; Torrico F; Tapia G; Van Leuven F; Araujo-Jorge TC
    Am J Trop Med Hyg; 1996 Feb; 54(2):154-61. PubMed ID: 8619440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Chagas' disease: plasma levels of alpha-2-macroglobulin and C-reactive protein in children under 13 years in a high endemic area of Bolivia.
    Medrano NM; Luz MR; Cabello PH; Tapia GT; Van Leuven F; Araújo-Jorge TC
    J Trop Pediatr; 1996 Apr; 42(2):68-74. PubMed ID: 8984217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial function and high-sensitivity C-reactive protein levels in patients with Chagas disease living in a nonendemic area].
    García-Álvarez A; Sitges M; Heras M; Poyatos S; Posada E; Pinazo MJ; Regueiro A; Gascon J; Sanz G
    Rev Esp Cardiol; 2011 Oct; 64(10):891-6. PubMed ID: 21802190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.
    Apt W; Arribada A; Zulantay I; Saavedra M; Araya E; Solari A; Ortiz S; Arriagada K; Rodríguez J
    Parasitol Res; 2015 Aug; 114(8):3007-18. PubMed ID: 25935204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic factor as marker of myocardial compromise in Chagas' disease.
    Puyó AM; Scaglione J; Auger S; Cavallero S; Donoso AS; Dupuy HA; Fernández BE
    Regul Pept; 2002 May; 105(2):139-43. PubMed ID: 11891014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi prevalence and clinical forms in blood donor candidates in Brazil.
    Silveira HJ; Mozart ON; Norberg AN; Pile EA
    Rev Saude Publica; 2003 Dec; 37(6):807-9. PubMed ID: 14666313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].
    Llano M; Pavía P; Flórez AC; Cuéllar A; González JM; Puerta C
    Biomedica; 2014; 34(2):228-36. PubMed ID: 24967928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to human heart conduction system in Chagas' disease.
    Arce-Fonseca M; Ballinas-Verdugo MA; Reyes PA; Aranda-Fraustro A; Monteón VM
    Vector Borne Zoonotic Dis; 2005; 5(3):233-6. PubMed ID: 16187891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients.
    Vasconcelos RH; Azevedo EA; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2011 May; 72(5):402-5. PubMed ID: 21371515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease.
    Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS
    Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?
    Lidani KC; Beltrame MH; Luz PR; Sandri TL; Nisihara RM; de Messias-Reaso IJ
    Int J Cardiol; 2015; 190():233-5. PubMed ID: 25920034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.